We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.57B
AUM Growth
-$44M
Cap. Flow
-$44.8M
Cap. Flow %
-2.86%
Top 10 Hldgs %
22.89%
Holding
416
New
226
Increased
51
Reduced
95
Closed
41

Top Buys

Rank Stock Value
1
CIXX
CI Financial Corp.
CIXX
+$18.8M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$15.5M
3
VRTS icon
Virtus Investment Partners
VRTS
+$12.4M
4
AMZN icon
Amazon
AMZN
+$12.1M
5
MED icon
Medifast
MED
+$11.4M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$28.8M
2
VOYA icon
Voya Financial
VOYA
+$24.9M
3
ELS icon
Equity Lifestyle Properties
ELS
+$23.4M
4
BNTX icon
BioNTech
BNTX
+$16.1M
5
INDA icon
iShares MSCI India ETF
INDA
+$15.5M

Sector Composition

Rank Sector Weight
1 Healthcare 52.77%
2 Consumer Discretionary 15.05%
3 Financials 13.41%
4 Technology 7.21%
5 Industrials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
51
NeoGenomics
NEO
$2.11B
$11.5M 0.74%
337,617
-246,664
-42% -$9.66M
QTRX icon
52
Quanterix
QTRX
$139M
$11.4M 0.73%
269,062
+22,758
+9% +$1.06M
GTHX
53
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$10.7M 0.68%
1,049,947
+88,808
+9% +$1.13M
KPTI icon
54
Karyopharm Therapeutics
KPTI
$46M
$10.7M 0.68%
110,536
+9,349
+9% +$932K
AMWL icon
55
American Well
AMWL
$215M
$10.1M 0.65%
83,734
+7,083
+9% +$1.08M
EDIT icon
56
Editas Medicine
EDIT
$436M
$8.32M 0.53%
313,322
+104,818
+50% +$3.61M
STRO icon
57
Sutro Biopharma
STRO
$353M
$7.86M 0.5%
52,844
+4,468
+9% +$800K
GOOG icon
58
Alphabet (Google) Class C
GOOG
$4.19T
$7.03M 0.45%
+48,620
New +$7.03M
TSLA icon
59
Tesla
TSLA
$1.29T
$6.73M 0.43%
+19,116
New +$6.41M
GOOGL icon
60
Alphabet (Google) Class A
GOOGL
$4.2T
$6.71M 0.43%
+46,340
New +$6.67M
YMAB
61
DELISTED
Y-mAbs Therapeutics
YMAB
$6.25M 0.4%
385,440
+32,601
+9% +$697K
TRHC
62
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$5.92M 0.38%
394,559
+33,372
+9% +$608K
MELI icon
63
Mercado Libre
MELI
$92.7B
$5.91M 0.38%
+4,380
New +$6.15M
META icon
64
Meta Platforms (Facebook)
META
$1.47T
$5.81M 0.37%
17,266
-6,039
-26% -$2M
NVAX icon
65
Novavax
NVAX
$1.31B
$5.56M 0.36%
38,881
-13,050
-25% -$2.24M
NVDA icon
66
NVIDIA
NVDA
$5.43T
$5.29M 0.34%
179,690
-45,560
-20% -$1.25M
SGFY
67
DELISTED
Signify Health, Inc.
SGFY
$4.68M 0.3%
329,345
+27,857
+9% +$431K
ADBE icon
68
Adobe
ADBE
$103B
$4.64M 0.3%
+8,184
New +$5.12M
JPM icon
69
JPMorgan Chase
JPM
$971B
$4.52M 0.29%
28,548
+1,317
+5% +$216K
NKE icon
70
Nike
NKE
$60.1B
$4.31M 0.28%
25,851
-2,118
-8% -$349K
CRM icon
71
Salesforce
CRM
$158B
$3.94M 0.25%
15,508
+658
+4% +$185K
KRRO icon
72
Korro Bio
KRRO
$197M
$3.63M 0.23%
14,141
+1,196
+9% +$364K
EL icon
73
Estee Lauder
EL
$31.7B
$3.58M 0.23%
+9,679
New +$3.29M
CCEP icon
74
Coca-Cola Europacific Partners
CCEP
$47.3B
$3.35M 0.21%
59,961
+1,352
+2% +$72.9K
GS icon
75
Goldman Sachs
GS
$302B
$3.16M 0.2%
+8,254
New +$3.27M
1 2
3
4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q4 2021 Portfolio in Review

As of Q4 2021, Lombard Odier Asset Management (Switzerland) held 416 positions worth $1.57B, down 2.7% from $1.61B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lombard Odier Asset Management (Switzerland)'s Q4 2021 filing shows 226 new, 51 increased, 95 reduced and 41 closed positions. Its largest new stake was CRISPR Therapeutics: 177,769 shares worth $13.5M. The largest sale was Merck, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Lombard Odier Asset Management (Switzerland)'s largest Q4 2021 buy was CRISPR Therapeutics: 177,769 shares worth $13.5M.
  • Lombard Odier Asset Management (Switzerland) added most to CI Financial Corp. in Q4 2021, an estimated $18.8M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q4 2021 reduction was Merck, cutting an estimated $28.8M.
  • Lombard Odier Asset Management (Switzerland) fully exited Voya Financial in Q4 2021, selling an estimated $24.9M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 23% of its $1.57B portfolio in Q4 2021.
  • Lombard Odier Asset Management (Switzerland) opened 226 new positions and closed 41 in Q4 2021.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 2.7% quarter-over-quarter to $1.57B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 14 Feb 2022.